Clinical Trials Browser

Phase 1 × CTL019 chimeric antigen receptor × Clear all

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Phase 1 Completed

26 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01551043 2020-07-09

Allo CART-19 Protocol

Phase 1 Terminated

2 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02810223 2016-10-14

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

20 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Allo CART-19 Protocol

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia